Parnax Lab Profit & Loss Annual

Trade
BSE: 506128 | NSE: - | ISIN: INE383L01019 | Sector: Biotechnology & Drugs
161.60 -0.80 (-0.49%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 188.71167.61163.0390.06
Total Revenue 188.71167.61163.0390.06
Costof Revenue Total 102.8189.6489.6441.76
Gross Profit 85.9077.9673.3948.30
Selling/ General/ Admin Expenses Total 23.7254.7217.4313.68
Depreciation/ Amortization 6.966.535.875.16
Other Operating Expenses Total 38.630.1832.9324.67
Total Operating Expense 172.13151.13145.8785.27
Operating Income 16.5816.4817.164.79
Interest Inc( Exp) Net- Non- Op Total -53.46-42.40-47.94-48.34
Other Net 0.820.03-0.11-0.04
Net Income Before Taxes 12.0512.2812.26-0.08
Provisionfor Income Taxes 2.423.654.010.28
Net Income After Taxes 9.628.638.26-0.36
Minority Interest -0.02-0.01-0.020.00
Net Income Before Extra Items 9.618.628.24-0.36
Net Income 9.618.628.24-0.36
Income Availableto Com Excl Extra Ord 9.618.628.24-0.36
Income Availableto Com Incl Extra Ord 9.618.628.24-0.36
Diluted Net Income 9.618.628.24-0.36
Diluted Weighted Average Shares 1.151.110.850.85
Diluted EPS Excluding Extra Ord Items 8.387.799.68-0.43
Diluted Normalized EPS 8.387.829.68-0.43
Unusual Expense( Income) -0.06--
Gain( Loss)on Saleof Assets -0.120.030.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts